The estimated Net Worth of Ltd. Bei Gene, is at least $20.4 Million dollars as of 24 September 2021. Ltd Gene owns over 2,543,800 units of Leap Therapeutics Inc stock worth over $20,355,170 and over the last 3 years Ltd sold LPTX stock worth over $0.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Sign up
Ltd Gene LPTX stock SEC Form 4 insiders trading
Ltd has made over 1 trades of the Leap Therapeutics Inc stock since 2021, according to the Form 4 filled with the SEC. Most recently Ltd bought 2,543,800 units of LPTX stock worth $7,249,830 on 24 September 2021.
The largest trade Ltd's ever made was buying 2,543,800 units of Leap Therapeutics Inc stock on 24 September 2021 worth over $7,249,830. On average, Ltd trades about 2,543,800 units every 0 days since 2021. As of 24 September 2021 Ltd still owns at least 7,348,437 units of Leap Therapeutics Inc stock.
You can see the complete history of Ltd Gene stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
What's Ltd Gene's mailing address?
Ltd's mailing address filed with the SEC is C/O MOURANT GOVERNANCE SERVICES (CAYMAN), 94 SOLARIS AVENUE, CAMANA BAY, GRAND CAYMAN, , KY1-1108.
Insiders trading at Leap Therapeutics Inc
Over the last 8 years, insiders at Leap Therapeutics Inc have traded over $0 worth of Leap Therapeutics Inc stock and bought 10,810,588 units worth $40,517,079 . The most active insiders traders include Advisors Llcperceptive Life..., Christopher Mirabelli, and Ltd. Bei Gene,. On average, Leap Therapeutics Inc executives and independent directors trade stock every 142 days with the average trade being worth of $1,990,710. The most recent stock trade was executed by Christopher Mirabelli on 26 January 2024, trading 5,000 units of LPTX stock currently worth $13,850.
What does Leap Therapeutics Inc do?
leap therapeutics (nasdaq: lptx) is a clinical-stage biopharmaceutical company acquiring and developing novel therapeutics at the leading edge of cancer research. for more information about leap therapeutics, visit http://www.leaptx.com or our public filings with the sec that are available via edgar at http://www.sec.gov or via http://www.investors.leaptx.com.
What does Leap Therapeutics Inc's logo look like?
Complete history of Ltd Gene stock trades at Leap Therapeutics Inc
Leap Therapeutics Inc executives and stock owners
Leap Therapeutics Inc executives and other stock owners filed with the SEC include:
-
Douglas Onsi,
President, Chief Executive Officer, Director -
Augustine Lawlor,
Chief Operating Officer -
Christopher Mirabelli,
Chairman of the Board -
Cynthia Sirard,
Chief Medical Officer -
Mark O'Mahony,
Chief Manufacturing Officer -
Nissim Mashiach,
Independent Director -
Joseph Loscalzo,
Independent Director -
William Li,
Independent Director -
Thomas Dietz,
Lead Independent Director -
James Cavanaugh,
Independent Director -
Monica Bertagnolli,
Independent Director -
John W Littlechild,
Director -
Ventures Ix, L.P.Healthcare...,
-
Harold R Werner,
10% owner -
Lilly & Co Eli,
10% owner -
Patricia A. Martin,
Director -
Christian M Richard,
Director -
Richard Schilsky,
Director -
Advisors Llcperceptive Life...,
-
Ventures Viii, L.P.Health C...,
-
Jason Baum,
Chief Scientific Officer -
Christine Granfield,
VP, Head of Reg Affairs/Qual -
Ltd. Bei Gene,,
10% owner